BU CTSI Awarded $38.3 Million Renewal from NIH

BU’s Clinical and Translational Science Institute (BU CTSI), led by Dr. David Center, Chief of the section of Pulmonary, Allergy, Sleep and Critical Care,  has been awarded $38.3 million in renewal funding from the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).

“This renewal, which will fund CTSI for another five years, comes in a timely fashion to help us invest in coronavirus-related science, epidemiology, and clinical research,” says David Center, director of BU CTSI. “We are well-poised to help fund translational research in COVID-19 because we already have an infrastructure that expedites the ability of BU’s investigators to get moving on studies and identify patients to enroll in new clinical trials. We’ve made an enormous difference getting patients into [COVID-19-related] clinical trials.”

Read More

View all posts